Skip Navigation
Skip to contents

Diabetes Metab J : Diabetes & Metabolism Journal

Search
OPEN ACCESS

Best practice

Page Path
HOME > About > Best practice
About

Principles of Transparency and Best Practice in Scholarly Publishing

Posted on May 1, 2023

Our journal adheres to Principles of Transparency and Best Practice in Scholarly Publishing (ver. 4, published September 15, 2022; https://doaj.org/apply/transparency) developed by Committee on Publication Ethics (COPE), the Directory of Open Access Journals (DOAJ), the Open Access Scholarly Publishing Association (OASPA), and the World Association of Medical Editors (WAME). Compliance checklist of the journal to the joint statement is as follows.

JOURNAL CONTENT JOURNAL PRACTICES ORGANISATION BUSINESS PRACTICES

JOURNAL CONTENT

1. Name of journal

The official journal title is Diabetes & Metabolism Journal (abbreviated as Diabetes Metab J or dmj).

2. Website

The official website of our journal is https://e-dmj.org. The dmj team endeavors to make a high-quality website with accurate information and adherence to ethical and professional standards. It does not contain any misleading information, including any attempts to mimic other journal/publisher websites. Information for authors and readers is described in detail on the journal website. Key information can be found by clicking on the headings below.

3. Publishing schedule

dmj is published bimonthly on the last day of January, March, May, July, September, and November. Additional supplementary or special issues may also be published.

4. Archiving

dmj provides the electronic backup and preservation of access to the journal content in the event the journal is no longer published by archiving in PubMed Central (https://www.ncbi.nlm.nih.gov/pmc/journals/1508/) since 2010 (from the 34th volume), Korea Citation Index (https://www.kci.go.kr/), and the National Library of Korea (https://nl.go.kr/). Authors can archive preprint (i.e., prerefereeing), postprint (i.e., final draft post-refereeing), and publisher’s version/PDF.

5. Copyright

The copyright, including the right of online transmission, is owned by the Korean Diabetes Association. All authors should sign and submit Copyright Transfer Agreement form during the submission process. Copyright information is indicated on all published papers (HTML and PDF) and on the dmj website.

6. Licensing

dmj is an open-access journal distributed under the terms of the Creative Commons License (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. To use the tables or figures of dmj in other journals, books, or media for scholarly, educational purposes, the process of permission request to the publisher of dmj is not necessary. All contents of the journal are available immediately upon publication without embargo period. Licensing information is indicated on all published papers (HTML and PDF) and on the dmj website.

JOURNAL PRACTICES

7. Publication ethics and related editorial policies

dmj adheres to the guideline of COPE (https://publicationethics.org), Recommendations of International Committee of Medical Journal Editors (https://www.icmje.org/recommendations). Our publication ethics are displayed on the Research and Publication Ethics tab of journal homepage.
In case the journal faces suspected cases of research and publication misconduct, such as redundant (duplicate) publication, plagiarism, fraudulent or fabricated data, changes in authorship, an undisclosed conflict of interest, ethical problems with a submitted manuscript, a reviewer who has appropriated an author’s idea or data, complaints against editors, and so on, the resolution process will follow the flowchart provided by COPE (https://publicationethics.org/resources/flowcharts). The discussion and decision on the suspected cases are carried out by the Editorial Board.

8. Peer review

dmj has an online submission and peer review system (https://submit.e-dmj.org/). Further details on peer review can be found under the Peer Review Policy section of the Editorial and Review Policy page. The basic policy is as follows.
All papers, including those invited by the editor, are subject to peer review. dmj has adopted a double-blind peer review policy, where the author identities remain anonymous to the reviewers, and vice versa and the identities of the reviewers and authors are visible to (decision-making) the editor throughout the peer review process. The Editorial Board selects reviewers based on expertise, publication history, and past reviews. During the peer review process, reviewers can interact directly or exchange information (e.g., via submission systems or email) with only an editor, which is known as “independent review.” An initial decision will normally be made within 2 weeks after the reviewers agree to review a manuscript. No information about the review process or editorial decision process is published on the article page.
All manuscripts from editors, employees, or members of the Editorial Board are processed the same way as other unsolicited manuscripts. During the review process, they will not engage in the selection of reviewers nor the decision process. Editors will not handle their own manuscripts even if they are commissioned ones.
All articles in dmj include the dates of submission, revision, acceptance, and publication on their article page.

9. Access

dmj is freely accessible from the journal website (https://e-dmj.org) according to the Creative Commons License (https://creativecommons.org/licenses/by/4.0/). A free full-text service both in the XML and PDF formats is available immediately upon publication without embargo period.

ORGANISATION

10. Ownership and management

The journal is owned by the publisher, the Korean Diabetes Association (http://www.diabetes.or.kr). The full names and affiliations of the members of the journal management team are displayed on the About (Management team) tab of the journal homepage.

11. Advisory body

The Editorial Board serves as the journal's advisory body. All Editorial Board members' names and affiliations are disclosed (Editorial board tab of the journal homepage), and their detailed information can be accessed via links to their ORCID and Scopus ID profiles.

12. Editorial Team and Contact Information

An editorial team in charge of managing and publishing the journal's content is displayed on the About (Management team) tab of the journal homepage, and the contact information for the Editor-in-Chief and the Editorial Office can be found on the About (Contact us) tab.

BUSINESS PRACTICES

13. Author fees

An article processing charge of $600 will be applicable for articles accepted for publication in the dmj. Submission of the article to the journal can be completed once the payment method has been agreed. Any applicable article processing charge must be paid before publication.
Effective January 1, 2023, an article processing charge of $600 will be applicable for non-industry-sponsored articles and $1,000 for industry-sponsored articles accepted for publication in the dmj. Invited review articles are exempt from article charges.
• Waiver policy
dmj offers waivers and discounts for authors based in low-income countries as classified by the World Bank (https://datahelpdesk.worldbank.org/knowledgebase/articles/906519/) as of July in the year before submission. Requests for waivers should be made at the time of submission. Please contact the editorial office (diabetes@kams.or.kr) to request a waiver. To ensure that a paper’s waiver status does not influence the editor’s decision, editors are not informed when a waiver has been granted.

14. Other revenue

The revenue sources of the Journal come from the support of the publisher (Korean Diabetes Association) and advertising rates.

15. Advertising

This academic journal and the advertisement price follow in accordance with the KRPIA Fair Competition Code and Working Guideline: https://www.krpia.or.kr/board/lists/fairRule. Any individuals or organizations who are interested in advertising their products or services are encouraged to contact the Editorial Office. The acceptance of advertisement will be discussed by the Editorial Board and will be ultimately approved by the publisher. Detailed information can be found on the Editorial Policy (Advertising Policy) tab.

16. Direct marketing

Journal propagation has been done through the journal website and distribution of an introduction pamphlet. Invitations to submit a manuscript are usually targeted towards presenters at conferences, seminars, or workshops related to the journal's aims and scope.
In addition, we declare that these principles acknowledge the responsibility of publishers and editors in promoting accessibility, diversity, equity, and inclusivity in all aspects of publication. Editorial decisions are based solely on scholarly merit, and should not be influenced by the authors' nationality, ethnicity, political beliefs, race, or religion. dmj is committed to ensuring that its policies do not create an exclusionary environment and will regularly evaluate them for inclusiveness.


Diabetes Metab J : Diabetes & Metabolism Journal
Close layer